| Impact of earlier diagnosis in cardiac ATTR amyloidosis over the course of 20 years A Ioannou, RK Patel, Y Razvi, A Porcari, G Sinagra, L Venneri, F Bandera, ... Circulation 146 (22), 1657-1670, 2022 | 231 | 2022 |
| Conventional heart failure therapy in cardiac ATTR amyloidosis A Ioannou, P Massa, RK Patel, Y Razvi, A Porcari, MU Rauf, A Jiang, ... European Heart Journal 44 (31), 2893-2907, 2023 | 135 | 2023 |
| Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment A Martinez-Naharro, R Patel, T Kotecha, N Karia, A Ioannou, A Petrie, ... European heart journal 43 (45), 4722-4735, 2022 | 122 | 2022 |
| SGLT2 inhibitor therapy in patients with transthyretin amyloid cardiomyopathy A Porcari, F Cappelli, C Nitsche, D Tomasoni, G Sinigiani, S Longhi, ... Journal of the American College of Cardiology 83 (24), 2411-2422, 2024 | 120 | 2024 |
| Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis MU Rauf, PN Hawkins, F Cappelli, F Perfetto, M Zampieri, A Argiro, ... European heart journal 44 (24), 2187-2198, 2023 | 99 | 2023 |
| Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy A Porcari, Y Razvi, A Masi, R Patel, A Ioannou, MU Rauf, DF Hutt, ... European journal of heart failure 25 (4), 515-524, 2023 | 95 | 2023 |
| Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis L Chacko, N Karia, L Venneri, F Bandera, BD Passo, L Buonamici, ... European Journal of Heart Failure 24 (9), 1700-1712, 2022 | 91 | 2022 |
| RNA targeting and gene editing strategies for transthyretin amyloidosis A Ioannou, M Fontana, JD Gillmore BioDrugs 37 (2), 127, 2023 | 85 | 2023 |
| Transvenous implantable cardioverter‐defibrillator (ICD) lead performance: a meta‐analysis of observational studies R Providência, DB Kramer, D Pimenta, GG Babu, LA Hatfield, A Ioannou, ... Journal of the American Heart Association 4 (11), e002418, 2015 | 85 | 2015 |
| Sex differences among patients with transthyretin amyloid cardiomyopathy–from diagnosis to prognosis RK Patel, A Ioannou, Y Razvi, L Chacko, L Venneri, F Bandera, D Knight, ... European journal of heart failure 24 (12), 2355-2363, 2022 | 83 | 2022 |
| Antibody-associated reversal of ATTR amyloidosis–related cardiomyopathy M Fontana, J Gilbertson, G Verona, M Riefolo, I Slamova, O Leone, ... New England Journal of Medicine 388 (23), 2199-2201, 2023 | 69 | 2023 |
| Stratifying disease progression in patients with cardiac ATTR amyloidosis A Ioannou, F Cappelli, M Emdin, C Nitsche, S Longhi, A Masri, A Cipriani, ... Journal of the American College of Cardiology 83 (14), 1276-1291, 2024 | 67 | 2024 |
| Efficacy and safety of ablation index-guided catheter ablation for atrial fibrillation: an updated meta-analysis A Ioannou, N Papageorgiou, WY Lim, T Wongwarawipat, RJ Hunter, ... EP Europace 22 (11), 1659-1671, 2020 | 67 | 2020 |
| Multi-imaging characterization of cardiac phenotype in different types of amyloidosis A Ioannou, RK Patel, Y Razvi, A Porcari, D Knight, A Martinez-Naharro, ... Cardiovascular Imaging 16 (4), 464-477, 2023 | 57 | 2023 |
| Inflammatory biomarkers in atrial fibrillation E Zacharia, N Papageorgiou, A Ioannou, G Siasos, S Papaioannou, ... Current medicinal chemistry 26 (5), 837-854, 2019 | 47 | 2019 |
| Pulmonary embolism in COVID-19: Clinical characteristics and cardiac implications J Kho, A Ioannou, K Van den Abbeele, AKJ Mandal, CG Missouris The American journal of emergency medicine 38 (10), 2142-2146, 2020 | 43 | 2020 |
| Prognostic value of a 6-minute walk test in patients with transthyretin cardiac amyloidosis A Ioannou, C Fumagalli, Y Razvi, A Porcari, MU Rauf, A Martinez-Naharro, ... Journal of the American College of Cardiology 84 (1), 43-58, 2024 | 40 | 2024 |
| Tracking treatment response in cardiac light-chain amyloidosis with native T1 mapping A Ioannou, RK Patel, A Martinez-Naharro, Y Razvi, A Porcari, MU Rauf, ... JAMA cardiology 8 (9), 848-852, 2023 | 39 | 2023 |
| Tracking multiorgan treatment response in systemic AL-amyloidosis with cardiac magnetic resonance derived extracellular volume mapping A Ioannou, RK Patel, A Martinez-Naharro, Y Razvi, A Porcari, DF Hutt, ... Cardiovascular Imaging 16 (8), 1038-1052, 2023 | 39 | 2023 |
| Myocardial perfusion in cardiac amyloidosis L Chacko, T Kotecha, A Ioannou, N Patel, A Martinez-Naharro, Y Razvi, ... European Journal of Heart Failure 26 (3), 598-609, 2024 | 34 | 2024 |
